Recruiting
Chronic obstructive pulmonary disease
RecruitingStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Registered drugNo placebo
Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Registered drugNo placebo
- Disease:Chronic obstructive pulmonary disease
- Substances:BudesonideSalbutamol+2
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:Budesonide
- Sponsor:AstraZeneca AB



